Therefore, in this study, the changes in the expression level of PTPRG protein were determined in the WBCs of seven healthy individuals and 21 CML patients at the time of diagnosis and following treatment with BCR-ABL TKIs, using flow cytometry. This evidence concerns the gene PTPRG and chronic myelogenous leukemia, BCR-ABL1 positive.